Mary Caitlin King

Ms. Mary Caitlin King

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2018 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
CMCarlos Munoz-Zuluaga
Carlos Munoz-Zuluaga
ASArmando Sardi
Armando Sardi
MKMary Caitlin King
Mary Caitlin King
CNCarol Nieroda
Carol Nieroda
MSMichelle Sittig
Michelle Sittig
VGVadim Gushchin
Vadim Gushchin

1 December 2019 in Journal of Global Oncology
Verified
Journal Article
Open access
ASArmando Sardi
Armando Sardi
MOMavalynne Orozco-Urdaneta
Mavalynne Orozco-Urdaneta
CVCarolina Velez-Mejia
Carolina Velez-Mejia
APAndres H. Perez-Bustos
Andres H. Perez-Bustos
CMCarlos Munoz-Zuluaga
Carlos Munoz-Zuluaga
JSJohn Singer
John Singer
Breast and cervical cancers are leading causes of mortality among women in Latin America. Colombia has universal health care and a government-sponsored 10-year cancer control plan focused on prevention, early detection, and treatment. However, many administrative and social barriers have hindered its success, and a majority of patients are diagnosed at a late stage. Established in 2012, Partners for Cancer Care and Prevention (PFCCAP) works to decrease the burden of these cancers by mitigating the obstacles women face during their cancer diagnosis and treatment. Through community outreach meetings with medical personnel, hospital directors, and government officials, PFCCAP identified major barriers, including lack of trained health care personnel, few centers with adequate screening equipment, and a fragmented health system with significant administrative delays and poor continuity of care. Its solution included monthly teleconferences, biannual on-site training, quality control programs, and improved access to screening equipment. PFCCAP also initiated a patient navigation project. After implementation of the PFCCAP plan of action, from 2012 to 2018, the average time from initial consult to biopsy decreased from 65 to 20 days; from biopsy to diagnosis, 33 to 4 days; and from diagnosis to surgery, 121 to 60 days. To date, more than 1,500 women have benefited from this initiative, which has expanded to other regions. Overall, PFCCAP is creating centers of excellence in strategically located hospitals and promoting the implementation of national guidelines. Although several barriers still exist, PFCCAP is helping to implement an efficient health care model that can be replicated in other underserved populations.

1 February 2021 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Andrei NikiforchinAndrei Nikiforchin
Andrei Nikiforchin
VGVadim Gushchin
Vadim Gushchin
MKMary Caitlin King
Mary Caitlin King
EBEkaterina Baron
Ekaterina Baron
CNCarol Nieroda
Carol Nieroda
ASArmando Sardi
Armando Sardi

1 September 2019 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
CMCarlos A. Munoz-Zuluaga
Carlos A. Munoz-Zuluaga
MKMary Caitlin King
Mary Caitlin King
PLPanayotis Ledakis
Panayotis Ledakis
VGVadim Gushchin
Vadim Gushchin
MSMichelle Sittig
Michelle Sittig
ASArmando Sardi
Armando Sardi

23 July 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
CMCarlos A. Munoz-Zuluaga
Carlos A. Munoz-Zuluaga
MKMary Caitlin King
Mary Caitlin King
VDVictor S. Diaz-Sarmiento
Victor S. Diaz-Sarmiento
KSKimberley Studeman
Kimberley Studeman
MSMichelle Sittig
Michelle Sittig
ASArmando Sardi
Armando Sardi

8 February 2022 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
FLFelipe Lopez-Ramirez
Felipe Lopez-Ramirez
VGVadim Gushchin
Vadim Gushchin
MSMichelle Sittig
Michelle Sittig
MKMary Caitlin King
Mary Caitlin King
EBEkaterina Baron
Ekaterina Baron
ASArmando Sardi
Armando Sardi